角化包膜前体蛋白与癌症发生发展的研究进展
Research Progress of Keratocapsular Precursor Protein in the Development of Cancer
DOI: 10.12677/acm.2026.1682932, PDF,    科研立项经费支持
作者: 黄榆喆*:内蒙古医科大学口腔医学院,内蒙古 呼和浩特;李丹苹, 潘庆斌#:广西医科大学口腔医学院(附属口腔医院)病理科,广西 南宁
关键词: 角化包膜;癌症;兜甲蛋白;富含脯氨酸小蛋白;内披蛋白;Cornified Envelope; Cancer; Loricrin; Small Proline-Rich Proteins; Involucrin
摘要: 角化包膜(cornified envelope, CE)前体蛋白是角化包膜的关键成分,对上皮屏障功能具有重要作用,可保护底层组织免受多种不利因素的影响。CE前体蛋白(包括兜甲蛋白、富含脯氨酸的小蛋白、内披蛋白、包膜蛋白、外周蛋白)经转谷氨酰胺酶交联形成刚性蛋白网络,并与ω-羟基神经酰胺共价键合,共同维系表皮屏障的完整性。近年来,越来越多的研究表明CE前体蛋白表达失调在癌症发生中扮演关键角色,不仅可能破坏物理屏障功能,还可能通过加剧氧化应激、增加基因组不稳定性以及增强致癌物渗透性等途径促进癌症发展。本文系统地综述了CE前体蛋白在癌前病变及恶性肿瘤中的作用机制及其临床意义,以期为靶向CE前体蛋白的癌症防治策略提供理论支持。
Abstract: As the key components of the cornified envelope (CE), cornified envelope precursor proteins play an important role in the epithelial barrier function and protect underlying tissues from a range of adverse factors. CE precursor proteins (including loricrin, small proline-rich proteins, involucrin, envoplakin and periplakin) are cross-linked by transglutaminases to form a rigid protein network and are covalently bonded to ω-hydroxy ceramides, collectively maintaining the integrity of the epidermal barrier. In recent years, accumulating evidence has shown that dysregulated CE precursor protein expression plays a key role in carcinogenesis and may not only potentially compromise the physical barrier function; it may also promote cancer development by exacerbating oxidative stress, increasing genomic instability, and enhancing carcinogen permeability. This review systematically summarizes the mechanistic and clinical significance of CE precursor proteins in precancerous lesions and malignant tumors, aiming to provide theoretical support for cancer prevention and treatment strategies targeting CE precursor proteins.
文章引用:黄榆喆, 李丹苹, 潘庆斌. 角化包膜前体蛋白与癌症发生发展的研究进展[J]. 临床医学进展, 2026, 16(8): 1534-1543. https://doi.org/10.12677/acm.2026.1682932

参考文献

[1] Nicolaou, A. and Kendall, A.C. (2024) Bioactive Lipids in the Skin Barrier Mediate Its Functionality in Health and Disease. Pharmacology & Therapeutics, 260, Article ID: 108681.
https://doi.org/10.1016/j.pharmthera.2024.108681
[2] Deng, Z., Cangkrama, M., Butt, T., Jane, S.M. and Carpinelli, M.R. (2021) Grainyhead‐Like Transcription Factors: Guardians of the Skin Barrier. Veterinary Dermatology, 32, 553-e152.
https://doi.org/10.1111/vde.12956
[3] Pancarte, M., Leignadier, J., Courrech, S., Serre, G., Attia, J. and Jonca, N. (2024) Strengthening the Skin Barrier by Using a Late Cornified Envelope 6A‐Derived Biomimetic Peptide. Experimental Dermatology, 33, e15191.
https://doi.org/10.1111/exd.15191
[4] Mischke, D., Korge, B.P., Marenholz, I., Volz, A. and Ziegler, A. (1996) Genes Encoding Structural Proteins of Epidermal Cornification and S100 Calcium-Binding Proteins Form a Gene Complex (“Epidermal Differentiation Complex”) on Human Chromosome 1q21. Journal of Investigative Dermatology, 106, 989-992.
https://doi.org/10.1111/1523-1747.ep12338501
[5] Wertz, P.W. (2025) A Provocation on Formation of the Corneocyte Lipid Envelope. Skin Pharmacology and Physiology, 38, 159-164.
https://doi.org/10.1159/000546731
[6] Moya-Garrido, P., Cano-Gómez, L.P., Ibarra-Molero, B., Godoy-Ruiz, R. and Medina-Carmona, E. (2026) Human Transglutaminases: Updated Insights into Activation Mechanisms, Allosteric Regulation and Disease. International Journal of Molecular Sciences, 27, Article 2976.
https://doi.org/10.3390/ijms27072976
[7] Ding, Y., Labitzky, V., Legler, K., Qi, M., Schumacher, U., Schmalfeldt, B., et al. (2021) Molecular Characteristics and Tumorigenicity of Ascites‐Derived Tumor Cells: Mitochondrial Oxidative Phosphorylation as a Novel Therapy Target in Ovarian Cancer. Molecular Oncology, 15, 3578-3595.
https://doi.org/10.1002/1878-0261.13028
[8] Zhang, S., Yao, H., Li, H., Su, T., Jiang, S., Wang, H., et al. (2023) Transglutaminases Are Oncogenic Biomarkers in Human Cancers and Therapeutic Targeting of TGM2 Blocks Chemoresistance and Macrophage Infiltration in Pancreatic Cancer. Cellular Oncology, 46, 1473-1492.
https://doi.org/10.1007/s13402-023-00824-7
[9] Chaudhary, R.K., Patil, P., Shetty, V.V., L., A., Shetty Kalladka, S., Mateti, U.V., et al. (2024) Decoding the Role of SPRR1A and SPRR1B Gene in Cancer: A Comprehensive Review. Gene Reports, 36, Article ID: 101926.
https://doi.org/10.1016/j.genrep.2024.101926
[10] Ishitsuka, Y. and Roop, D.R. (2022) Loricrin at the Boundary between inside and outside. Biomolecules, 12, Article 673.
https://doi.org/10.3390/biom12050673
[11] Wang, S. and Zhang, W. (2022) Small Proline-Rich Protein 1A Promotes Lung Adenocarcinoma Progression and Indicates Unfavorable Clinical Outcomes. Biochemistry and Cell Biology, 100, 199-212.
https://doi.org/10.1139/bcb-2021-0348
[12] Yang, S., Kang, W., Choi, D., Roh, J. and Park, T. (2024) Dihydromyrcenol Modulates Involucrin Expression through the Akt Signaling Pathway. International Journal of Molecular Sciences, 25, Article 2246.
https://doi.org/10.3390/ijms25042246
[13] Liu, L., Ding, L., Zhang, L., Zhang, H., Zhang, Y. and Liu, D. (2022) Mechanism of Periplakin on Ovarian Cancer Cell Phenotype and Its Influence on Prognosis. Translational Cancer Research, 11, 1372-1385.
https://doi.org/10.21037/tcr-22-1090
[14] Huang, C., Chen, Y., Bhutani, M.S., Wang, C., Zhou, Y., Guo, J., et al. (2025) The Plakin Family: Potential Therapeutic Targets for Digestive System Tumors. Journal of Translational Internal Medicine, 13, 397-409.
https://doi.org/10.1515/jtim-2025-0033
[15] Natsuga, K., Cipolat, S. and Watt, F.M. (2016) Increased Bacterial Load and Expression of Antimicrobial Peptides in Skin of Barrier-Deficient Mice with Reduced Cancer Susceptibility. Journal of Investigative Dermatology, 136, 99-106.
https://doi.org/10.1038/jid.2015.383
[16] Cipolat, S., Hoste, E., Natsuga, K., Quist, S.R. and Watt, F.M. (2014) Epidermal Barrier Defects Link Atopic Dermatitis with Altered Skin Cancer Susceptibility. eLife, 3, e01888.
https://doi.org/10.7554/elife.01888
[17] Shen, Y., Sun, W. and Dai, C. (2026) Comprehensive Analysis to Reveal Nitrogen Metabolism-Associated Genes as a Prognostic Index in Head and Neck Squamous Cell Cancer. Current Medicinal Chemistry, 33, 3313-3336.
https://doi.org/10.2174/0109298673427009251022060122
[18] Chatterjee, R., Ghosh, B., Mandal, M., Nawn, D., Banerjee, S., Pal, M., et al. (2021) Pathophysiological Relationship between Hypoxia Associated Oxidative Stress, Epithelial-Mesenchymal Transition, Stemness Acquisition and Alteration of Shh/Gli-1 Axis during Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma. European Journal of Cell Biology, 100, Article ID: 151146.
https://doi.org/10.1016/j.ejcb.2020.151146
[19] Preetika, S., Indhuja, V. and Sowmya, C. (2023) Oral Submucous Fibrosis: A Review on Current Treatment Approaches. World Journal of Biology Pharmacy and Health Sciences, 13, 157-162.
https://doi.org/10.30574/wjbphs.2023.13.2.0088
[20] Dash, K., Mahapatra, N., Bhuyan, L., Panda, A., Behura, S. and Mishra, P. (2020) Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis. Journal of Pharmacy and Bioallied Sciences, 12, 264-267.
https://doi.org/10.4103/jpbs.jpbs_79_20
[21] Odani, T., Ito, D., Li, M., Kawamata, A., Isobe, T., Iwase, M., et al. (2006) Gene Expression Profiles of Oral Leukoplakia and Carcinoma: Genome-Wide Comparison Analysis Using Oligonucleotide Microarray Technology. International Journal of Oncology, 28, 619-624.
https://doi.org/10.3892/ijo.28.3.619
[22] Pandey, S., Søland, T.M., Bjerkli, I.H., Sand, L.P., Petersen, F.C., Costea, D.E., et al. (2021) Combined Loss of Expression of Involucrin and Cytokeratin 13 Is Associated with Poor Prognosis in Squamous Cell Carcinoma of Mobile Tongue. Head & Neck, 43, 3374-3385.
https://doi.org/10.1002/hed.26826
[23] Lee, M.K., Joo, H., Bae, M., Lee, Y., Noh, J., Lee, Y.C., et al. (2026) Keratinization-Related Gene Signature Predicting Survival and Response to Radiation in Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma via Regulation of Cornification and Integrin Signaling. Cellular & Molecular Biology Letters, 31, Article No. 26.
https://doi.org/10.1186/s11658-025-00855-y
[24] Chou, S., Azuma, Y., Varia, M.A. and Raleigh, J.A. (2004) Evidence That Involucrin, a Marker for Differentiation, Is Oxygen Regulated in Human Squamous Cell Carcinomas. British Journal of Cancer, 90, 728-735.
https://doi.org/10.1038/sj.bjc.6601585
[25] Sasahira, T., Kurihara-Shimomura, M., Shimomura, H., Bosserhoff, A.K. and Kirita, T. (2021) Identification of Oral Squamous Cell Carcinoma Markers MUC2 and SPRR1B Downstream of Tango. Journal of Cancer Research and Clinical Oncology, 147, 1659-1672.
https://doi.org/10.1007/s00432-021-03568-9
[26] Burian, A., Lujber, L., Gerlinger, I., Jarai, T., Orosz, E., Turiak, L., et al. (2020) Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples—A Pilot Study. Pathology & Oncology Research, 26, 2801-2807.
https://doi.org/10.1007/s12253-020-00849-5
[27] Ogawa, T., Ishitsuka, Y., Nakamura, Y., Watanabe, R., Okiyama, N., Fujisawa, Y., et al. (2022) Loricrin Protects against Chemical Carcinogenesis. Journal of Investigative Dermatology, 142, 2023-2026.e1.
https://doi.org/10.1016/j.jid.2021.12.015
[28] Santiago, J.L., Muñoz-Rodriguez, J.R., Cruz-Morcillo, M.A.D.L., Villar-Rodriguez, C., Gonzalez-Lopez, L., Aguado, C., et al. (2021) Characterization of Permeability Barrier Dysfunction in a Murine Model of Cutaneous Field Cancerization Following Chronic UV-B Irradiation: Implications for the Pathogenesis of Skin Cancer. Cancers, 13, Article 3935.
https://doi.org/10.3390/cancers13163935
[29] Liu, B., Park, E., Zhu, F., Bustos, T., Liu, J., Shen, J., et al. (2006) A Critical Role for IκB Kinase Α in the Development of Human and Mouse Squamous Cell Carcinomas. Proceedings of the National Academy of Sciences of the United States of America, 103, 17202-17207.
https://doi.org/10.1073/pnas.0604481103
[30] Ewen, T., Husain, A., Stefanos, N., Barrett, P., Jones, C., Ness, T., et al. (2023) Validation of Epidermal AMBRA1 and Loricrin (AMBLor) as a Prognostic Biomarker for Nonulcerated American Joint Committee on Cancer Stage I/II Cutaneous Melanoma. British Journal of Dermatology, 190, 549-558.
https://doi.org/10.1093/bjd/ljad459
[31] Cosgarea, I., McConnell, A.T., Ewen, T., Tang, D., Hill, D.S., Anagnostou, M., et al. (2021) Melanoma Secretion of Transforming Growth Factor‐β2 Leads to Loss of Epidermal AMBRA1 Threatening Epidermal Integrity and Facilitating Tumour Ulceration. British Journal of Dermatology, 186, 694-704.
https://doi.org/10.1111/bjd.20889
[32] Cai, W. and Chen, M. (2024) Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma through the RAS/ERK Signaling Pathway. Journal of Inflammation Research, 17, 1687-1706.
https://doi.org/10.2147/jir.s447934
[33] Li, B., Wang, X., Zhou, F., Saunders, N.A., Frazer, I.H. and Zhao, K. (2008) Up-Regulated Expression of Sp1 Protein Coincident with a Viral Protein in Human and Mouse Differentiating Keratinocytes May Act as a Cell Differentiation Marker. Differentiation, 76, 1068-1080.
https://doi.org/10.1111/j.1432-0436.2008.00300.x
[34] Nishimori, T., Tomonaga, T., Matsushita, K., Oh‐Ishi, M., Kodera, Y., Maeda, T., et al. (2006) Proteomic Analysis of Primary Esophageal Squamous Cell Carcinoma Reveals Downregulation of a Cell Adhesion Protein, Periplakin. Proteomics, 6, 1011-1018.
https://doi.org/10.1002/pmic.200500262
[35] Otsubo, T., Hagiwara, T., Tamura‐Nakano, M., Sezaki, T., Miyake, O., Hinohara, C., et al. (2015) Aberrant DNA Hypermethylation Reduces the Expression of the Desmosome‐Related Molecule Periplakin in Esophageal Squamous Cell Carcinoma. Cancer Medicine, 4, 415-425.
https://doi.org/10.1002/cam4.369
[36] Roy, R.R., Shimada, K., Murakami, S. and Hasegawa, H. (2021) Contribution of Transglutaminases and Their Substrate Proteins to the Formation of Cornified Cell Envelope in Oral Mucosal Epithelium. European Journal of Oral Sciences, 129, e12760.
https://doi.org/10.1111/eos.12760
[37] Song, T., Chen, J., Xing, P., Hao, H., Yang, X., Chen, B., et al. (2025) Multi-OMIC Profiling Identifies KRT1 as a Predictor of Immune Infiltration and Prognosis in Gastroesophageal Junction Cancer. Functional & Integrative Genomics, 25, Article No. 89.
https://doi.org/10.1007/s10142-025-01595-0
[38] Sun, S., Huang, F., Xu, X., Xu, K., Peng, T., Bai, W., et al. (2024) Development and Validation of a Prediction Model for Gastric Cancer: A Single-Center Prospective Study. Laboratory Medicine, 56, 31-36.
https://doi.org/10.1093/labmed/lmae060
[39] 许晓明, 董学妍, 陈岳明, 余道军, 王贤军. 富含脯氨酸小蛋白2A对胃癌细胞增殖和迁移能力的影响[J]. 实用肿瘤杂志, 2020, 35(6): 511-517.
[40] Yao, L., Yan, J., Cheng, F., Gan, L., Huang, Y., Zheng, L., et al. (2021) Small Proline-Rich Protein 2B Facilitates Gastric Adenocarcinoma Proliferation via MDM2-p53/p21 Signaling Pathway. OncoTargets and Therapy, 14, 1453-1463.
https://doi.org/10.2147/ott.s281032
[41] Li, X., Zhang, G., Wang, Y., Elgehama, A., Sun, Y., Li, L., et al. (2017) Loss of Periplakin Expression Is Associated with the Tumorigenesis of Colorectal Carcinoma. Biomedicine & Pharmacotherapy, 87, 366-374.
https://doi.org/10.1016/j.biopha.2016.12.103
[42] Zhang, Z., Shi, R., Xu, S., Li, Y., Zhang, H., Liu, M., et al. (2021) Identification of Small Proline‐Rich Protein 1B (SPRR1B) as a Prognostically Predictive Biomarker for Lung Adenocarcinoma by Integrative Bioinformatic Analysis. Thoracic Cancer, 12, 796-806.
https://doi.org/10.1111/1759-7714.13836
[43] Yu, L., Yang, Z., Liu, Y., Liu, F., Shang, W., Shao, W., et al. (2020) Identification of SPRR3 as a Novel Diagnostic/Prognostic Biomarker for Oral Squamous Cell Carcinoma via RNA Sequencing and Bioinformatic Analyses. PeerJ, 8, e9393.
https://doi.org/10.7717/peerj.9393
[44] Box, C., Pennington, C., Hare, S., Porter, S., Edwards, D., Eccles, S., et al. (2023) Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3. International Journal of Molecular Sciences, 24, Article 10757.
https://doi.org/10.3390/ijms241310757
[45] Geay, J., Margaron, Y., Gentien, D., Reyal, F., Puisieux, A., Blanchoin, L., et al. (2024) Plakins Are Involved in the Regulation of Centrosome Position in Polarized Epithelial Cells. Biology of the Cell, 116, e2400048.
https://doi.org/10.1111/boc.202400048
[46] Cheng, H., Wang, R., Lu, L., Gong, Y., Li, L. and Wang, Z. (2024) Bladder Cancer Patients with Elevated SPRR1B Expression Experiencing a Poor Prognosis. Archivos Españoles de Urología, 77, 554-569.
https://doi.org/10.56434/j.arch.esp.urol.20247705.76
[47] Matsumoto, K., Ikeda, M., Matsumoto, T., Nagashio, R., Nishimori, T., Tomonaga, T., et al. (2014) Serum Periplakin as a Potential Biomarker for Urothelial Carcinoma of the Urinary Bladder. Asian Pacific Journal of Cancer Prevention, 15, 9927-9931.
https://doi.org/10.7314/apjcp.2014.15.22.9927
[48] Wesley, T., Escalona, R.M., Kannourakis, G. and Ahmed, N. (2024) Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and in Silico Datasets. Cancers, 16, Article 4087.
https://doi.org/10.3390/cancers16234087
[49] Hua, T., Zhao, B.B., Fan, S.B., Zhao, C.F., Kong, Y.H., Tian, R.Q., et al. (2022) Prognostic Implications of PPL Expression in Ovarian Cancer. Discover Oncology, 13, Article No. 35.
https://doi.org/10.1007/s12672-022-00496-z
[50] Al-Jassar, C., Bernadό, P., Chidgey, M. and Overduin, M. (2013) Hinged Plakin Domains Provide Specialized Degrees of Articulation in Envoplakin, Periplakin and Desmoplakin. PLOS ONE, 8, e69767.
https://doi.org/10.1371/journal.pone.0069767
[51] Spain, F., Gimenez, D., Acevedo-Jake, A.M., Mylemans, B., Brooks, N.J., Korona, B., et al. (2026) De novo Grafted Coiled-Coil Peptides as p53/hDM2 Inhibitors. RSC Chemical Biology, 7, 1589-1596.
https://doi.org/10.1039/d6cb00063k
[52] Yamakawa, K., Koyanagi-Aoi, M., Uehara, K., Masuda, A., Yanagimoto, H., Toyama, H., et al. (2022) Increased Expression of SPRR1A Is Associated with a Poor Prognosis in Pancreatic Ductal Adenocarcinoma. PLOS ONE, 17, e0266620.
https://doi.org/10.1371/journal.pone.0266620
[53] Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., et al. (2025) SPRR1A Is a Potential Therapeutic Target for Osteosarcoma: In Vitro and in Vivo Evaluations Using Generated Artificial Osteosarcoma Cancer Stem Cell-Like Cells. Oncology Reports, 53, Article No. 24.
https://doi.org/10.3892/or.2024.8857
[54] Zabini, A., Zimmer, Y. and Medová, M. (2023) Beyond Keratinocyte Differentiation: Emerging New Biology of Small Proline-Rich Proteins. Trends in Cell Biology, 33, 5-8.
https://doi.org/10.1016/j.tcb.2022.08.002
[55] Wu, M., Guo, Q., Liu, X. and Wu, L. (2022) SPRR3, a Novel miR-338-3p Target, Regulates the Malignant Progression of Clear Cell Renal Cell Carcinoma in Vitro via the PI3K/Akt Signaling Pathway. Experimental and Therapeutic Medicine, 23, Article No. 317.
https://doi.org/10.3892/etm.2022.11246
[56] Shi, Y.X. (2026) Multi-Omics Analysis Identified SPRR2D as a Potential Biomarker for Tumor Prognosis and Immune Microenvironment Infiltration: A Pan-Cancer Perspective. Future Science OA, 12, Article ID: 2653101.
https://doi.org/10.1080/20565623.2026.2653101